BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38211574)

  • 1. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
    Yanxia C; Xiongyi Y; Min F; Xiaoyun K
    Ophthalmic Res; 2024; 67(1):96-106. PubMed ID: 38211574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
    Tang L; Luo D; Qiu Q; Xu GT; Zhang J
    Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
    Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
    Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema.
    Yu L; Hao X; Cheng J; Ling Y; Ren H; Mo B; Liu W
    BMC Ophthalmol; 2023 May; 23(1):232. PubMed ID: 37221461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early anti-VEGF Treatment Response.
    Yalinbas Yeter D; Eroglu S; Sariakcali B; Bozali E; Vural Ozec A; Erdogan H
    Ocul Immunol Inflamm; 2022 May; 30(4):901-906. PubMed ID: 33596398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema.
    Chatziralli I; Dimitriou E; Lambadiari V; Kazantzis D; Kapsis P; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Semin Ophthalmol; 2022 Jul; 37(5):668-675. PubMed ID: 35468026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.
    Zhou J; Song S; Zhang Y; Jin K; Ye J
    Ophthalmol Ther; 2022 Dec; 11(6):2153-2167. PubMed ID: 36166152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
    Liu S; Wang D; Chen F; Zhang X
    BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy.
    Huang CH; Yang CH; Hsieh YT; Yang CM; Ho TC; Lai TT
    Sci Rep; 2021 Mar; 11(1):5103. PubMed ID: 33658601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.
    Kaya M; Atas F; Kocak N; Ozturk T; Ayhan Z; Kaynak S
    Curr Eye Res; 2023 May; 48(5):498-505. PubMed ID: 36629472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
    Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of retinal fluid in patients with diabetic macular edema treated with anti-VEGF in routine clinical practice.
    Kalur A; Iyer AI; Muste JC; Talcott KE; Singh RP
    Can J Ophthalmol; 2023 Aug; 58(4):271-277. PubMed ID: 35395214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study.
    Saurabh K; Roy R; Herekar S; Mistry S; Choudhari S
    Indian J Ophthalmol; 2021 Nov; 69(11):3203-3206. PubMed ID: 34708773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: A systematic review and meta-analysis.
    Gong Y; Wang M; Li Q; Shao Y; Li X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103555. PubMed ID: 37088331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.